Bach Ardalan

University of Miami — United States

Medicine · Health Sciences

26h-index2.4kcitations149works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(43), Gastric Cancer Management and Outcomes(27), Pancreatic and Hepatic Oncology Research(23), Biochemical and Molecular Research(23), Esophageal Cancer Research and Treatment(18)

Publications149 total

Supplementary Table S2 from Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma
2025Open Access
Supplementary Table S5 from Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma
2025Open Access
Supplementary Table S1 from Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma
2025Open Access
Supplementary Table S3 from Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma
2025Open Access
Data from Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma
2025· 1 citedOpen Access
Supplementary Table S4 from Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma
2025Open Access
Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma
Clinical Cancer Research·2025· 11 citedOpen Access
Metastatic Pancreatic Adenocarcinoma Downstaged to T0N0 with Chemotherapy and Targeted Therapy, Confirmed by Surgical Pathology: A Case Report
Case Reports in Oncology·2024Open Access
Anti-Proliferative and Anti-Cancer Properties of Achyranthes Aspera: Specific Inhibitory Activity Against Pancreatic Cancer Cells
2024Open Access
Anti-Proliferative and Anti-Cancer Properties of Achyranthes Aspera: Specific Inhibitory Activity Against Pancreatic Cancer Cells
2024
Nab-paclitaxel and gemcitabine (modified) in combination with oral cobimetinib and encorafenib following FOLFIRINOX in patients with metastatic G12D and G12V pancreatic cancer.
Journal of Clinical Oncology·2024
Case report: Diagnosis of NUT carcinoma of hepatic origin by next-generation sequencing
Frontiers in Oncology·2024· 4 citedOpen Access
Not all treated <i>KRAS-</i>mutant pancreatic adenocarcinomas are equal: <i>KRAS </i>G12D and survival outcome.
Journal of Clinical Oncology·2023· 9 cited
<i>KRAS </i>G12C-mutated pancreatic cancer: Clinical outcomes based on chemotherapeutic regimen.
Journal of Clinical Oncology·2023· 3 cited
Prognostic indicators of KRAS G12X mutations in pancreatic cancer.
Journal of Clinical Oncology·2023· 8 cited
Mini-Review: Pancreatic Cancer Presenting as a Bowel Obstruction and the Role of Next-Generation Sequencing
Journal of Cancer Treatment and Diagnosis·2022Open Access
Pancreatic cancer presenting as bowel obstruction and role of next generation sequencing: A case report
International Journal of Surgery Case Reports·2021· 4 citedOpen Access
Potential benefit of treatment with MEK inhibitors and chemotherapy in BRAF-mutated KRAS wild-type pancreatic ductal adenocarcinoma patients: a case report
Molecular Case Studies·2021· 12 citedOpen Access
Cobimetinib Plus Gemcitabine: An Active Combination in KRAS G12R-Mutated Pancreatic Ductal Adenocarcinoma Patients in Previously Treated and Failed Multiple Chemotherapies
Journal of Pancreatic Cancer·2021· 16 citedOpen Access
Implementation of hepatic artery infusion (HAI) chemotherapy for unresectable colorectal liver metastases (CRLM): The University of Miami experience.
Journal of Clinical Oncology·2021· 1 cited
page 1 of 8Next →

Frequent Co-authors

Alan S. Livingstone(11), Pochi R. Subbarayan(9), Pasquale Benedetto(8), Niramol Savaraj(7), Lynn G. Feun(6), Stephen P. Richman(5), Louise Morrell(5), David A. Cooney(5), Hiremagalur N. Jayaram(5), Dido Franceschi(5), Stuart Waldman(4), John S. Macdonald(4), Malancha Sarkar(4), K. Rajender Reddy(3), Robert I. Glazer(3), Mayra Lima(3), D. Mezentsev(3), Joé U. Levi(3), Eugene R. Schiff(3), Thomas R. Fleming(2)